Business Context and Reporting Period
This Form 8-K is a current report filed by ReWalk Robotics Ltd. (noting the input metadata reference to "Lifeward Ltd." appears to be an error as the filing explicitly names ReWalk Robotics) on May 5, 2020. The registrant is incorporated in Israel and its ordinary shares trade on the Nasdaq Capital Market under the symbol RWLK. The filing addresses corporate governance matters regarding the upcoming 2020 Annual Meeting of Shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly informational regarding shareholder meeting procedures and does not contain financial statements or performance data.
Material Changes
There are no material changes to financial operations or business strategy reported in this document. The primary update concerns the scheduling of the 2020 Annual Meeting of Shareholders, which has been set for June 18, 2020. Because this date is more than 30 days following the anniversary of the 2019 Annual Meeting, the deadlines for shareholder proposals have been extended.
Guidance, Outlook, and Corporate Actions
- Annual Meeting Date: June 18, 2020.
- Shareholder Proposal Deadline (Rule 14a-8): Proposals for inclusion in proxy materials must be received by May 10, 2020.
- Director Nominations and Other Business: Written notice for business not pursuant to Rule 14a-8, including director nominations, must be received by May 12, 2020.
- Submission Address: Proposals must be sent to the Chief Financial Officer at the company's principal executive offices in Yokneam Ilit, Israel.
Key Facts for Investor Verification
- Verify the correct registrant name is ReWalk Robotics Ltd. (RWLK), not Lifeward Ltd.
- Confirm the deadline for submitting shareholder proposals for the 2020 Annual Meeting is May 10, 2020.
- Note the separate deadline of May 12, 2020, for director nominations and other business items under Israeli law and the Articles of Association.
- Check the definitive proxy statement (Schedule 14A) for further details on the agenda once filed.